Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community‐based naloxone distribution strategies in Massachusetts, United States
Addiction · 2025
DOI: 10.1111/add.16691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2025. Verfasst von Xiao Zang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Health Services Accessibility, Naloxone, Narcotic Antagonists, Opiate Overdose. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, National Institutes on Drug Abuse.
Abstract (Originalsprache)
Background and Aims During the COVID‐19 pandemic, there was a surge in opioid overdose deaths (OODs) in Massachusetts, USA, particularly among Black and Hispanic/Latinx populations. Despite the increasing racial and ethnic disparities in OODs, there was no compensatory increase in naloxone distributed to these groups. We aimed to evaluate two community‐based naloxone expansion strategies, with the objective of identifying approaches that could mitigate mortality and racial and ethnic disparities in OODs.
Design
Individual‐based simulation model. We measured naloxone availability using naloxone kits per OOD and evaluated scenarios of achieving higher benchmarks for naloxone availability (i.e. 40, 60 and 80 kits per OOD) from 2022 levels (overall: 26.0, White: 28.8, Black: 17.3, Hispanic/Latinx: 18.9). We compared two naloxone distribution strategies: (1) proportional distribution: achieving the benchmark ratio at the overall population level while distributing additional kits proportional to the 2022 level for each racial/ethnic group (at 40 kits per OOD benchmark: overall: 40, White: 44.3, Black: 26.6, Hispanic/Latinx: 29.1), and (2) equity‐focused distribution: achieving the benchmark ratio among each racial/ethnic group (at 40 kits per OOD benchmark: 40 for all groups).
Setting
Massachusetts, United States.
Participants
People at risk of OOD.
Measurements
Annual number and rate of OODs, total healthcare costs of increasing naloxone availability.
Findings
Both naloxone distribution strategies yielded comparable predicted reductions in total OODs in 2025 and incurred similar incremental costs. However, the relative reduction in the rate of OODs differed across groups. For achieving an 80 kits per OOD benchmark, proportional distribution resulted in a projected 6.7%, 6.5% and 7.1% reduction in annual OODs in 2025 among White, Black and Hispanic/Latinx populations, respectively. In contrast, equity‐focused distribution achieved a reduction of 5.7%, 11.3% and 10.2% in the respective groups. In all scenarios, the cost per OOD averted was lower than the generally accepted thresholds for cost per life saved.
Conclusions
An equity‐focused naloxone distribution strategy designed to reduce racial and ethnic disparities in naloxone availability could improve health equity among racial and ethnic groups while potentially improving overall population health at lower healthcare costs per opioid overdose death averted than a proportional distribution strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
- Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA.
- Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.
- Department of Medicine, Section of General Internal Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
- Center for Drug Use and HIV/HCV Research, New York, NY, USA.
- Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA, USA.
ORCID-Profile: Xiao Zang, Zongbo Li, Czarina N Behrends, Ali Jalali, Jake R Morgan, Bruce R Schackman, Brandon D L Marshall
Förderung
- NIDA NIH HHS
- National Institutes on Drug Abuse
Zitieren
APA
Zang, X., Skinner, A., Li, Z., Shaw, L. C., Behrends, C. N., Chatterjee, A., Jalali, A., Jordan, A. E., Morgan, J. R., Nolen, S., Schackman, B. R., Marshall, B. D. L., & Walley, A. Y. (2025). Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community‐based naloxone distribution strategies in Massachusetts, United States. Addiction. https://doi.org/10.1111/add.16691
Vancouver
Zang X, Skinner A, Li Z, Shaw LC, Behrends CN, Chatterjee A, et al. Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community‐based naloxone distribution strategies in Massachusetts, United States. Addiction. 2025. doi:10.1111/add.16691
BibTeX
@article{Zang2025,
author = {Zang, Xiao and Skinner, Alexandra and Li, Zongbo and Shaw, Leah C and Behrends, Czarina N and Chatterjee, Avik and Jalali, Ali and Jordan, Ashly E and Morgan, Jake R and Nolen, Shayla and Schackman, Bruce R and Marshall, Brandon D L and Walley, Alexander Y},
title = {Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community‐based naloxone distribution strategies in Massachusetts, United States},
journal = {Addiction},
year = {2025},
doi = {10.1111/add.16691}
}
EUVIMED